Hello, everybody. Welcome back to psychedelics today. This is Joe Moore coming at you from

Breckenridge, Colorado. Today on the show, we have James Lantier of Mindset Pharma, CEO over there. Mindset Farmer is doing some really

interesting stuff. Pretty, pretty excited. You know, novel molecules, like second generation,

you know, drugs, like why this is important is something we get into quite a bit. And, um, you know, I really just appreciate this approach. It's novel. It's exciting. Uh, there's new possibilities. When new molecules come around, there's new possibilities of what we can do with them. So yeah, so, so like, you know, stay tuned. Like there's a lot of groups doing this kind of stuff.

It's, you know, I have no idea who's going to be a winner.

No one does.

Biotech is a really, really wild industry. But it really pushes science forward.

And, you know, honestly, since the federal government's really not putting much research dollars into psychedelics.

It's really on the people and on corporations.

It's a really develop these science here.

So this is why I'm thankful.

I'm really happy, really serious people are digging in.

And yeah, it's it's fantastic.

So James, thanks for joining. Thanks for the work you do.

Excited to keep tabs. And yeah, just appreciate you coming in. So I think that's it for

now, everybody. Thanks for tuning in. I think on with the show, but first, a couple ads.

Just a couple of quick announcements.

The first of which is a philosophy and psychedelics conference happening the 28th, 29th, 30th of June in Exeter, England.

So our friends at the University of Exeter doing a hybrid conference, which means you can be there in person or tune in virtually.

The website is www.philosophy of psychedelics.com.

Hello, everybody. Welcome back to psychedelics. This is Joe Moore, joined by James Lontia, CEO of Mindset Pharma. How are you doing today, James?

Great, Joe. Nice to see you again. Thanks for having me on. Absolutely. Excited to dig in here.

...